TCTR20230510005已完成4 期
Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: A randomized control trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Adult kidney transplant recipients (age > 15 years old) who receive immunosuppressive agents at least 3 months
排除标准
- •Adult kidney transplant recipients (age > 15 years old) who receive influenza vaccination within 6 months
研究者
相似试验
已完成
3 期
Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: A randomized control trialPatients living with HIVHIV, immunocompromised, CD4 countTCTR20230501002Faculty of Medicine Ramathibodi Hospital, Mahidol University120
进行中（未招募）
不适用
Immunological and virological effects of high dose intravenous immunoglobulin (IVIG) treatment added to antiretroviral therapy against HIVEUCTR2005-003422-26-SEGöteborg University5
进行中（未招募）
1 期
Study to Assess the Immuno Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in European Adults 60 Years and OlderEUCTR2019-000655-14-BESanofi Pasteur1,540
已完成
3 期
Immunogenicity and Safety of a High-Dose Quadrivalent Influenza Vaccine Administered by the Intramuscular Route in Subjects 60 Years of Age and OlderFlu10047438InfluenzaNL-OMON48124Sanofi-aventis340
进行中（未招募）
1 期
Study to Assess the Immuno Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in European Adults 60 Years and OlderPrevention of influenza infection in adults from 60 years of age and olderMedDRA version: 20.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-000655-14-DESanofi Pasteur1,540